New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Novel allogeneic CAR T cell therapy shows promising results in patients with metastatic clear cell renal cell carcinoma

Novel allogeneic CAR T cell therapy shows promising results in patients with metastatic clear cell renal cell carcinoma

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Pixabay/CC0 Public DomainThe CD70-targeting allogeneic chimeric antigen receptor (CAR) T cell therapy, ALLO-316, demonstrated encouragin
Oncology January 15,2024
Novel allogeneic CAR T cell therapy shows promising results in patients with metastatic clear cell renal cell carcinoma

Novel allogeneic CAR T cell therapy shows promising results in patients with metastatic clear cell renal cell carcinoma

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Pixabay/CC0 Public DomainThe CD70-targeting allogeneic chimeric antigen receptor (CAR) T cell therapy, ALLO-316, demonstrated encouragin
Oncology January 15,2024
Endometriosis can complicate hysterectomies, study shows

Endometriosis can complicate hysterectomies, study shows

byUT Southwestern Medical CenterCredit: Pixabay/CC0 Public DomainPatients with endometriosis are more likely to experience complications during and after hysterectomies, a study by UT Southweste
OB & GYN January 15,2024
Endometriosis can complicate hysterectomies, study shows

Endometriosis can complicate hysterectomies, study shows

byUT Southwestern Medical CenterCredit: Pixabay/CC0 Public DomainPatients with endometriosis are more likely to experience complications during and after hysterectomies, a study by UT Southweste
OB & GYN January 15,2024
Maternal vaccination rates increasing steadily in NSW, but coverage inequalities remain

Maternal vaccination rates increasing steadily in NSW, but coverage inequalities remain

by National Centre for Immunisation Research and Surveillance (NCIRS)Credit: Laura Garcia from PexelsA new population-based study published in the journalVaccine, has shown that 54% of women who
OB & GYN January 15,2024
Maternal vaccination rates increasing steadily in NSW, but coverage inequalities remain

Maternal vaccination rates increasing steadily in NSW, but coverage inequalities remain

by National Centre for Immunisation Research and Surveillance (NCIRS)Credit: Laura Garcia from PexelsA new population-based study published in the journalVaccine, has shown that 54% of women who
OB & GYN January 15,2024
Birth rates have risen in states with abortion bans

Birth rates have risen in states with abortion bans

by Ernie MundellNew data shows that births rose in the first half of 2023 in states where abortion bans came into effect following the fall of Roe v. Wade in 2022.States with bans had an average 2.3%
OB & GYN January 15,2024
Birth rates have risen in states with abortion bans

Birth rates have risen in states with abortion bans

by Ernie MundellNew data shows that births rose in the first half of 2023 in states where abortion bans came into effect following the fall of Roe v. Wade in 2022.States with bans had an average 2.3%
OB & GYN January 15,2024
US woman with rare double uterus expecting babies in both

US woman with rare double uterus expecting babies in both

Credit: Pixabay/CC0 Public DomainIt's double trouble, with a unique twist: A 32-year-old woman from Alabama who was born with two uteruses is now pregnant in both.Kelsey Hatcher, who is documentin
OB & GYN January 15,2024
US woman with rare double uterus expecting babies in both

US woman with rare double uterus expecting babies in both

Credit: Pixabay/CC0 Public DomainIt's double trouble, with a unique twist: A 32-year-old woman from Alabama who was born with two uteruses is now pregnant in both.Kelsey Hatcher, who is documentin
OB & GYN January 15,2024
Next-generation trial shows five-drug combo can keep 'ultra-high-risk' bone marrow cancer at bay

Next-generation trial shows five-drug combo can keep 'ultra-high-risk' bone marrow cancer at bay

byInstitute of Cancer ResearchImmunofluorescent image of autophagosomes in multiple myeloma cells. Credit: Institute of Cancer ResearchCombining five existing drugs can keep a highly aggressive
Oncology January 15,2024
Next-generation trial shows five-drug combo can keep 'ultra-high-risk' bone marrow cancer at bay

Next-generation trial shows five-drug combo can keep 'ultra-high-risk' bone marrow cancer at bay

byInstitute of Cancer ResearchImmunofluorescent image of autophagosomes in multiple myeloma cells. Credit: Institute of Cancer ResearchCombining five existing drugs can keep a highly aggressive
Oncology January 15,2024
High rates of severe maternal trauma during forceps, vacuum births in Canada warrant national response, analysis shows

High rates of severe maternal trauma during forceps, vacuum births in Canada warrant national response, analysis shows

byMcMaster UniversityCredit: CC0 Public DomainA McMaster University-led analysis published in theBMJon Oct. 19, exposes high rates of injuries with forceps and vacuum delivery in Can
OB & GYN January 15,2024
High rates of severe maternal trauma during forceps, vacuum births in Canada warrant national response, analysis shows

High rates of severe maternal trauma during forceps, vacuum births in Canada warrant national response, analysis shows

byMcMaster UniversityCredit: CC0 Public DomainA McMaster University-led analysis published in theBMJon Oct. 19, exposes high rates of injuries with forceps and vacuum delivery in Can
OB & GYN January 15,2024
Study finds TNF blockers are not associated with poor pregnancy outcomes

Study finds TNF blockers are not associated with poor pregnancy outcomes

byAmerican College of RheumatologyCredit: Pixabay/CC0 Public DomainAccording tonew researchatACR Convergence 2023, the American College of Rheumatology's (ACR) annual meeti
OB & GYN January 15,2024
Study finds TNF blockers are not associated with poor pregnancy outcomes

Study finds TNF blockers are not associated with poor pregnancy outcomes

byAmerican College of RheumatologyCredit: Pixabay/CC0 Public DomainAccording tonew researchatACR Convergence 2023, the American College of Rheumatology's (ACR) annual meeti
OB & GYN January 15,2024
Prenatal exposure to lead linked to lower birth weights, earlier births in gold mining communities

Prenatal exposure to lead linked to lower birth weights, earlier births in gold mining communities

byDuke UniversityCredit: CC0 Public DomainA new study on the impacts of prenatal exposure to toxic metals linked to artisanal gold mining and other sources in Madre de Dios, Peru, finds that mer
OB & GYN January 15,2024
Prenatal exposure to lead linked to lower birth weights, earlier births in gold mining communities

Prenatal exposure to lead linked to lower birth weights, earlier births in gold mining communities

byDuke UniversityCredit: CC0 Public DomainA new study on the impacts of prenatal exposure to toxic metals linked to artisanal gold mining and other sources in Madre de Dios, Peru, finds that mer
OB & GYN January 15,2024
Study shows prophylactic low-dose aspirin in pregnancy does not increase IBD activity

Study shows prophylactic low-dose aspirin in pregnancy does not increase IBD activity

by Lori SolomonUse of low-dose aspirin (LDA) among pregnant women with inflammatory bowel disease (IBD) is not associated with an increased risk for disease activity, according to a study presented at
OB & GYN January 15,2024
Study shows prophylactic low-dose aspirin in pregnancy does not increase IBD activity

Study shows prophylactic low-dose aspirin in pregnancy does not increase IBD activity

by Lori SolomonUse of low-dose aspirin (LDA) among pregnant women with inflammatory bowel disease (IBD) is not associated with an increased risk for disease activity, according to a study presented at
OB & GYN January 15,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com